Astrazeneca Pharma India Ltd

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you on the change in role of Mr. Atul Tandon Business Unit Head - Oncology. He will be transitioning from the said role with effect from close of business hours on July 31 2023 as he takes up another responsibility within AstraZeneca group. In the interim the Oncology Business Unit of the Company will be managed by Mr. Ayush Kumar Agarwal who is currently the Director - Commercial Excellence.